News
Pfizer standalone net profit rises 65.72% in the September 2026 quarter
03-Nov-2026 | 16:23
Sales rise 13.16% to Rs 726.86 crore
Net profit of Pfizer rose 65.72% to Rs 313.25 crore in the quarter ended September 2026 as against Rs 189.02 crore during the previous quarter ended September 2025. Sales rose 13.16% to Rs 726.86 crore in the quarter ended September 2026 as against Rs 642.34 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 726.86 | 642.34 | 13 |
| OPM % | 35.94 | 35.80 | - |
| PBDT | 305.18 | 269.65 | 13 |
| PBT | 290.77 | 255.37 | 14 |
| NP | 313.25 | 189.02 | 66 |
Powered by Capital Market - Live News